Turner NC, Alarcon E, Armstrong AC, Philco M, et al. BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK Ann Oncol 2019;30:774-780.
PMID: 31987344